CVE-2026-73293Semaphore UI: Manager-to-owner privilege escalation via custom-role slug collision
Updated under an hour ago ()
Does this affect you?
It affects semaphoreui semaphore. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Semaphore UI is a web interface for managing DevOps tools. Prior to 2.18.19 and from 2.19.0-alpha3 until 2.19.5-beta5, ProjectMiddleware and GetProjectOrGlobalRoleBySlug allow a project manager to use POST /api/project/{id}/roles to create a custom manager role with permission bitmask 15, overriding the built-in manager permissions and granting CanUpdateProject and CanManageProjectUsers owner capabilities. This issue is fixed in versions 2.18.19 and 2.19.5-beta5.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-269
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Deferred
- Record last updated
- Aug 12, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
semaphoreui semaphore semaphoreui:semaphore (from the name) | before 2.18.19; from 2.19.0-alpha3, < 2.19.5-beta5 | CNA record |
References
- https://github.com/semaphoreui/semaphore/security/advisories/GHSA-cxvf-gvfq-36w2x-refsource-confirm
- https://github.com/semaphoreui/semaphore/commit/1c4bb65df114962134f8829d4a03667106a01a68x-refsource-misc
- https://github.com/semaphoreui/semaphore/commit/bb2a4e1f08c8023e618f8dd6eaca73554f2c33bbx-refsource-misc
- https://github.com/semaphoreui/semaphore/releases/tag/v2.18.19x-refsource-misc
- https://github.com/semaphoreui/semaphore/releases/tag/v2.19.5-beta5x-refsource-misc
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.